Searched for
CENTER FOR DRUG EVALUATION
These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...- FDA expands recall to all Clover Hill Dairy cheeses after listeria found in products and facilityUS food safety authorities have expanded a cheese recall due to Listeria contamination, now encompassing all products from Clover Hill Dair...
- Death rate in ICE immigrant detention centers more than doubles under Trump, Reuters analysis findsFifty individuals have died in U.S. immigration detention since January 2025, a rate that has more than doubled since 2009. Concerns are ri...
- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- From diapers to drugs: How India's global corporate hubs are putting AI to workHeads of several Global Capability Centres (GCCs) told Reuters they are deploying AI across a host of functions - from marketing and conten...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Eli Lilly’s obesity drug shows up to 30% weight loss in trialEli Lilly's new obesity drug retatrutide shows remarkable results. In a major trial, patients lost up to 30% of their body weight. This onc...
- FDA drug center head fired after commissioner's exit, replaced by DavisThe U.S. Food and Drug Administration's drug center sees a leadership change as acting head Tracy Beth Hoeg departs, replaced by deputy Mic...
- Stocks in news: HAL, TMPV, Bharti Airtel, Anant Raj, Zydus Life, Tata MotorsIndian markets experienced a volatile yet stable session after a sharp sell-off, with the Nifty showing resilience. Key companies like HAL,...
- Vijay sworn in as Tamil Nadu CM: Here's what TVK promised ahead of Assembly pollsTamil actor Vijay's party, Tamilaga Vettri Kazhagam, has taken charge as Tamil Nadu's new government. Vijay is now the Chief Minister. The ...
- What is mifepristone, and why is it used? Court restricts abortion access by blocking mailing of abortion pill in USWhat is mifepristone, and why is it used? A federal appeals court has restricted access to mifepristone by blocking mailing of prescription...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
- Amazon launches AI research tool to speed early-stage drug discoveryAmazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...
- J&K LG says admin will confiscate property, revoke passports, Aadhar cards and freeze accounts of drug smugglersJammu and Kashmir administration will take stringent action against drug smugglers. Properties will be seized, and licenses, passports, and...
- Controversial FDA official Dr Vinay Prasad regains Chief Medical Officer titleDr. Vinayak Prasad has been re-appointed as the FDA's Chief Medical and Scientific Officer and Director of CBER. He will advise senior offi...
- USFDA okays Merck's Covid Drug for use in high-risk casesThe USFDA also said molnupiravir should be given to those for whom alternative Covid-19 treatment options authorised by it are not accessib...
- No USFDA approval for SPARC's anti-Glaucoma eyedropWhile the FDA did not seek any additional information for supporting clinical data, it sought additional information on certain labeling of...
- Indian companies in FDA's first list for generic Aciphex tabletsIndian firms including Dr Reddy's, Lupin and Torrent Pharma have received nod from the US health regulator to market the first generic vers...
- US to hike fees for generic drugmakers; Indian firms to be hitUS health regulator FDA is hiking the fees for generic drugmakers by up to 48 per cent from October, that will hit Indian drugmakers.
- FDA reviewing Ranbaxy corrective action planUS health regulator FDA is working on a corrective action plan submitted by Ranbaxy Laboratories after 30 medicines of company manufactured...
Load More
